Capital-E invests as co-lead investor an additional 1.3 million € in Trinean NV

Wednesday, 20 october 2008

The investment is part of a total new funding round of 3.5 million €. Besides the existing investors Capital-E and Baekeland fonds (II), Vesalius BioCapital joins in as new investor.

Trinean (www.trinean.com) is a spin-off of the University of Ghent (Intec) and the Belgium nanoelectronics research center IMEC. The company develops and markets the first nanoliter spectrophotometer with corresponding micro fluidic consumables allowing full spectrum UV/VIS spectroscopic measurements in droplets of liquids between 0,5 and 2,5 µL in a microplate format in a very fast and automated way.

The initial target application is the determination of DNA/RNA concentrations in small sample volumes. This is of great importance to the biotech industry where today valuable DNA/RNA material has to be sacrificed in order to measure these concentrations, and where test procedures are time consuming.

Next to DNA/RNA quantification, other applications will also be targeted such as ADME testing, protein concentration measurements, enzymology, nephelometry and clinical
diagnostics.

The investment round will allow Trinean to start production, bring its products to the market and develop new applications.

The company is run by a senior management team consisting of Jan Boon (COO), (ex- Elscolab, Thermo Life Sciences, Flow Laboratories , Pharmacia Diagnostics….) and Prof. Marc Zabeau (CEO) (ex- Plant Genetic Systems, Helix, KeyeGene, Genscope, Methexis…)

About Capital-E
Capital-E is an early stage venture fund focused exclusively on micro- and nanoelectronics related ventures in Europe. We help initiate and grow businesses with venture capital, sound advice and access to a broad industry network and research ecosystem. Through its entrenched relationship with IMEC, the largest independent research centre in micro- and nano-electronics in Europe, the fund and its ventures can directly rely on the support of over 1500 specialized scientists and engineers, as well as leverage on IMEC’s 500+ worldwide industrial partners such as NXP, Infineon, STMicroelectronics, Intel, Panasonic, Texas Instruments, Samsung and TSMC to speedup the process of market entry. The fund is managed by an independent team with a balanced mix of entrepreneurial, industrial and VC experience. More information can be obtained at www.capital-e.com .

Publisher Contact Information:

Trinean
-
-

Company profile of Trinean
Past press releases of Trinean.